Vigilant Biosciences’ Scientific Founder and Chief Scientific Officer, Elizabeth Franzmann, M.D., is Honored by Greater Miami Chamber of Commerce with 2016 Health Care Heroes® Award

Vigilant Biosciences’ Scientific Founder and Chief Scientific Officer, Elizabeth Franzmann, M.D., is Honored by Greater Miami Chamber of Commerce with 2016 Health Care Heroes® Award May 17, 2016 FORT LAUDERDALE, Florida Vigilant Biosciences, Inc. (“Vigilant”), a leading innovator and developer of solutions that aid in the early detection and intervention of cancer, announced today that

Vigilant Biosciences Receives CE Mark for OncAlert® Oral Cancer RAPID Test to Aid in Diagnosis of Oral Cancer

Vigilant Biosciences Receives CE Mark for OncAlert® Oral Cancer RAPID Test to Aid in Diagnosis of Oral Cancer May 4, 2016 FORT LAUDERDALE, Florida Vigilant Biosciences, Inc. (“Vigilant”), a leading innovator and developer of solutions that aid in the early detection and intervention of cancer, today announced that it has CE Marked its OncAlert® Oral Cancer

National Oral Cancer Awareness Survey Reveals 83 Percent of Adults Want to be Screened for Oral Cancer During Routine Check-ups; Only 37 Percent Actually Are

National Oral Cancer Awareness Survey Reveals 83 Percent of Adults Want to be Screened for Oral Cancer During Routine Check-ups; Only 37 Percent Actually Are April 5, 2016 FORT LAUDERDALE, Florida A recent national consumer survey revealed that among U.S. adults, the majority knows very little or nothing at all about oral cancer (58 percent)

Vigilant Biosciences Announces Publication of Research on Risk Stratification System for Oral Cancer Screening

Vigilant Biosciences Announces Publication of Research on Risk Stratification System for Oral Cancer Screening March 31, 2016 FORT LAUDERDALE, Florida Vigilant Biosciences, Inc. (“Vigilant”), a leading innovator and developer of solutions that aid in the early detection and intervention of cancer, today announced that Cancer Prevention Research, a peer-reviewed medical journal of the American Association

Vigilant Biosciences Announces Poster Session on Risk Stratification System for Oral Cancer Screening at Inaugural Global Oral Cancer Forum

Vigilant Biosciences Announces Poster Session on Risk Stratification System for Oral Cancer Screening at Inaugural Global Oral Cancer Forum March 2, 2016 FORT LAUDERDALE, Florida Vigilant Biosciences, Inc. (“Vigilant”), a leading innovator and developer of solutions that aid in the early detection and intervention of cancer, today announced a presentation of data related to proof-of-concept

Vigilant Biosciences to Present at the Biotech Showcase™ 2016

Vigilant Biosciences to Present at the Biotech Showcase™ 2016 January 6, 2016 FORT LAUDERDALE, Florida Vigilant Biosciences, Inc. (“Vigilant”), a leading innovator and developer of solutions that aid in the early detection and intervention of cancer, today announced that Matthew Kim, Founder, Chairman and CEO of Vigilant Biosciences, Inc., will present at the Biotech Showcase™ 2016,

Vigilant Biosciences Selects Cardinal Health as Global Third Party Logistics Provider for OncAlert® Oral Cancer Product Line

Vigilant Biosciences Selects Cardinal Health as Global Third Party Logistics Provider for OncAlert® Oral Cancer Product Line November 18, 2015 FORT LAUDERDALE, Florida Vigilant Biosciences, Inc., a leading innovator and developer of solutions that aid in the early detection and intervention of cancer, announced today that it has selected Cardinal Health, Inc., a leading healthcare

Vigilant Biosciences Announces Distribution Agreements for OncAlert™ Oral Cancer Product Line for Czech Republic and Slovakia, Israel and Baltic Region

Vigilant Biosciences Announces Distribution Agreements for OncAlert™ Oral Cancer Product Line for Czech Republic and Slovakia, Israel and Baltic Region November 17, 2015 FORT LAUDERDALE, Florida Vigilant Biosciences, Inc., a leading innovator and developer of solutions that aid in the early detection and intervention of cancer, announced today three exclusive multi-year distribution agreements for sales

Vigilant Biosciences Receives CE Mark for OncAlert™ Oral Cancer LAB Test to Aid in Diagnosis of Oral Cancer

Vigilant Biosciences Receives CE Mark for OncAlert™ Oral Cancer LAB Test to Aid in Diagnosis of Oral Cancer November 16, 2015 FORT LAUDERDALE, Florida Vigilant Biosciences, Inc., a leading innovator and developer of solutions that aid in the early detection and intervention of cancer, announced today that it has CE Marked its OncAlert™ Oral Cancer

Vigilant Biosciences CEO, Matthew H.J. Kim, is Honored by BioFlorida with Weaver H. Gaines Entrepreneur of the Year Award

Vigilant Biosciences CEO, Matthew H.J. Kim, is Honored by BioFlorida with Weaver H. Gaines Entrepreneur of the Year Award October 13, 2015 FORT LAUDERDALE, Florida Vigilant Biosciences, Inc. (“Vigilant”), a leading innovator and developer of solutions that aid in the early detection and intervention of cancer, announced today that BioFlorida has awarded Vigilant’s founder and

© 2020 Vigilant Biosciences

Follow Us

3900001 Rev2